These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28065484)

  • 1. Predictors of favourable outcome in young people with a first episode psychosis without antipsychotic medication.
    Conus P; Cotton SM; Francey SM; O'Donoghue B; Schimmelmann BG; McGorry PD; Lambert M
    Schizophr Res; 2017 Jul; 185():130-136. PubMed ID: 28065484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm or aggression. Study protocol and baseline characteristics of participants.
    O'Donoghue B; Francey SM; Nelson B; Ratheesh A; Allott K; Graham J; Baldwin L; Alvarez-Jimenez M; Thompson A; Fornito A; Polari A; Berk M; Macneil C; Crisp K; Pantelis C; Yuen HP; Harrigan S; McGorry P
    Early Interv Psychiatry; 2019 Aug; 13(4):953-960. PubMed ID: 30024100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates and predictors of 18-months remission in an epidemiological cohort of 661 patients with first-episode psychosis.
    Conus P; Cotton S; Schimmelmann BG; McGorry PD; Lambert M
    Soc Psychiatry Psychiatr Epidemiol; 2017 Sep; 52(9):1089-1099. PubMed ID: 28477070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis.
    Lambert M; Conus P; Cotton S; Robinson J; McGorry PD; Schimmelmann BG
    J Clin Psychopharmacol; 2010 Oct; 30(5):565-72. PubMed ID: 20814327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate of and time to symptomatic remission in first-episode psychosis in Northern Malawi: A STROBE-compliant article.
    Kaminga AC; Dai W; Liu A; Myaba J; Banda R; Wen SW; Pan X
    Medicine (Baltimore); 2018 Nov; 97(45):e13078. PubMed ID: 30407306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis.
    Wils RS; Gotfredsen DR; Hjorthøj C; Austin SF; Albert N; Secher RG; Thorup AA; Mors O; Nordentoft M
    Schizophr Res; 2017 Apr; 182():42-48. PubMed ID: 28277310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting 1-year risk for relapse in patients who have discontinued or continued quetiapine after remission from first-episode psychosis.
    Hui CL; Wong GH; Tang JY; Chang WC; Chan SK; Lee EH; Lam MM; Chiu CP; Law CW; Chung DW; Tso S; Pang EP; Chan KT; Wong YC; Mo FY; Chan KP; Hung SF; Honer WG; Chen EY
    Schizophr Res; 2013 Oct; 150(1):297-302. PubMed ID: 23993865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.
    Alvarez-Jimenez M; O'Donoghue B; Thompson A; Gleeson JF; Bendall S; Gonzalez-Blanch C; Killackey E; Wunderink L; McGorry PD
    CNS Drugs; 2016 May; 30(5):357-68. PubMed ID: 27106296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rates and predictors of relapse following discontinuation of antipsychotic medication after a first episode of psychosis.
    Bowtell M; Eaton S; Thien K; Bardell-Williams M; Downey L; Ratheesh A; Killackey E; McGorry P; O'Donoghue B
    Schizophr Res; 2018 May; 195():231-236. PubMed ID: 29066258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial.
    Begemann MJH; Thompson IA; Veling W; Gangadin SS; Geraets CNW; van 't Hag E; Müller-Kuperus SJ; Oomen PP; Voppel AE; van der Gaag M; Kikkert MJ; Van Os J; Smit HFE; Knegtering RH; Wiersma S; Stouten LH; Gijsman HJ; Wunderink L; Staring ABP; Veerman SRT; Mahabir AGS; Kurkamp J; Pijnenborg GHM; Veen ND; Marcelis M; Grootens KP; Faber G; van Beveren NJ; Been A; van den Brink T; Bak M; van Amelsvoort TAMJ; Ruissen A; Blanke C; Groen K; de Haan L; Sommer IEC
    Trials; 2020 Feb; 21(1):147. PubMed ID: 32033579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of substance use reduction in an epidemiological first-episode psychosis cohort.
    Rebgetz S; Conus P; Hides L; Kavanagh DJ; Cotton S; Schimmelmann BG; McGorry PD; Lambert M
    Early Interv Psychiatry; 2014 Nov; 8(4):358-65. PubMed ID: 23879875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort.
    Schimmelmann BG; Huber CG; Lambert M; Cotton S; McGorry PD; Conus P
    J Psychiatr Res; 2008 Oct; 42(12):982-90. PubMed ID: 18199456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index.
    Haring L; Koido K; Vasar V; Leping V; Zilmer K; Zilmer M; Vasar E
    Schizophr Res; 2015 Dec; 169(1-3):22-29. PubMed ID: 26364730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-sectional observational study of healthcare professional views of factors affecting teenage adherence with antipsychotic medication.
    Ramdour S; Duxbury JA; Becket G; Wilson S
    J Psychiatr Ment Health Nurs; 2015 Sep; 22(7):491-501. PubMed ID: 25990303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for antipsychotic medication non-adherence behaviors and attitudes in adult-onset psychosis.
    Hui CLM; Poon VWY; Ko WT; Miao HY; Chang WC; Lee EHM; Chan SKW; Lin J; Chen EYH
    Schizophr Res; 2016 Jul; 174(1-3):144-149. PubMed ID: 27050476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate and predictors of service disengagement in an epidemiological first-episode psychosis cohort.
    Conus P; Lambert M; Cotton S; Bonsack C; McGorry PD; Schimmelmann BG
    Schizophr Res; 2010 May; 118(1-3):256-63. PubMed ID: 20206475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early recovery and employment outcome 13 years after first episode psychosis.
    Strålin P; Skott M; Cullberg J
    Psychiatry Res; 2019 Jan; 271():374-380. PubMed ID: 30529874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy challenges in patients with first-episode psychosis.
    Abdel-Baki A; Ouellet-Plamondon C; Malla A
    J Affect Disord; 2012; 138 Suppl():S3-14. PubMed ID: 22405590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effectiveness and tolerability of aripiprazole as initial choice of treatment in first episode psychosis in an early intervention service: A one-year outcome study.
    Malla A; Mustafa S; Rho A; Abadi S; Lepage M; Joober R
    Schizophr Res; 2016 Jul; 174(1-3):120-125. PubMed ID: 27157800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical recovery in first-episode psychosis.
    Wunderink L; Sytema S; Nienhuis FJ; Wiersma D
    Schizophr Bull; 2009 Mar; 35(2):362-9. PubMed ID: 18990715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.